Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 14 , ISSUE 5 ( September-October, 2022 ) > List of Articles

ORIGINAL RESEARCH

Mortality Risk among Pregnant Women during COVID-19 Pandemic: A Case–Control Study in Rajasthan

Aditi Bansal, Sapna Choudhary, Pushpa Nagar, Nivesh Lal, Preeti Gupta

Keywords : Comorbidity, COVID-19, Mortality risk, Pregnant women

Citation Information : Bansal A, Choudhary S, Nagar P, Lal N, Gupta P. Mortality Risk among Pregnant Women during COVID-19 Pandemic: A Case–Control Study in Rajasthan. J South Asian Feder Obs Gynae 2022; 14 (5):602-605.

DOI: 10.5005/jp-journals-10006-2130

License: CC BY-NC 4.0

Published Online: 16-11-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Objective: To analyze the risk factors associated with mortality in COVID-positive pregnant women. Material and methods: The study was designed as a case–control study and was conducted at COVID-designated tertiary care hospital. It included 42 deceased and 96 RT-PCR-positive surviving pregnant women who developed severe forms of disease. All the affected patients were admitted and managed according to Indian national guidelines. Risk factors – age, residence, socioeconomic status, gestation age, parity, and comorbidities were evaluated for their association with mortality. Results: Advanced maternal age (>28 years), rural residence, diabetes, and comorbidities were found to be associated with increased risk of mortality among the COVID-affected pregnant women, the respective adjusted odds ratio was 15.45, 12.61, 2.65, and 4.77, respectively. Conclusion: Pregnant women are vulnerable to COVID infection. They were at higher risk of mortality with comorbidities, advanced age, and low access to healthcare in the rural areas.


PDF Share
  1. Wegmann TG, Lin H, Guilbert L, et al. Bidirectional cytokine interactions in the maternal fetal relationship: Is successful pregnancy a Th2 phenomenon. Immunol Today 1993;14(7):353–356. DOI: 10.1016/0167-5699(93)90235-D.
  2. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis 2006;12(11):1638–1643. DOI: 10.3201/eid1211.060152.
  3. Pazos M, Sperling RS, Moran TM, et al. The influence of pregnancy on systemic immunity. Immunol Res 2012;54(1–3):254–261. DOI: 10.1007/s12026-012-8303-9.
  4. Forbes RL, Gibson PG, Murphy VE, et al. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax 2012;67(3):209–214. DOI: 10.1136/thoraxjnl-2011-200708.
  5. Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status – United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69(44): 1641–1647. DOI: 10.15585/mmwr.mm6944e3.
  6. Royal College of Obstetricians and Gynaecologists. Coronovirus (COVID-19) Infection in Pregnancy. Information for Healthcare Professionals. RCOG: London 2020;1(1):148–150.
  7. Samji P, Manoj KR. Effect of COVID-19 on pregnancy and childbirth. Indian J Obstet Gynecol Res 2020;7(2):296–299. DOI: 10.18231/j.ijogr. 2020.065.
  8. Ministry of Health and Family Welfare. Clinical Management Protocol for COVID-19. Available from: https://www.mohfw.dated27062020.pdf. Accessed on: May 21, 2021.
  9. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ 2020;370:m3320. DOI: 10.1136/bmj.m3320.
  10. Nwafor JI, Joseph KA, Anozie BO, et al. Pregnant women's knowledge and practice of preventive measures against COVID-19 in a low-resource African setting. Int J Obstet Gynecol 2020:1–3. DOI: 10.1002/ijgo.13186.
  11. Vouga M, Favre G, Martinez-Perez O, et al. Maternal outcomes and risk factors for COVID-19 severity among pregnant women. Sci Rep 2021;11(1):13898. DOI: 10.1038/s41598-021-92357-y.
  12. Fuso L, Pitocco D, Antonelli-Incalzi R. Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension. Diabetes Metab Res Rev 2019;35(6):e3159. DOI: 10.1002/dmrr.3159.
  13. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181(2):271–280.e8. DOI: 10.1016/j.cell.2020.02.052.
  14. Papapanou M, Papaioannou M, Petta A, et al. Maternal and neonatal characteristics and outcomes of COVID-19 in pregnancy: An overview of systematic reviews. Int J Environ Res Public Health 2021;18(2):596. DOI: 10.3390/ijerph18020596.
  15. Nakamura-Pereira M, Betina Andreucci C, de Oliveira Menezes M, et al. Worldwide maternal deaths due to COVID-19: A brief review. Int J Gynaecol Obstet 2020;151(1):148–150. DOI: 10.1002/ijgo.13328.
  16. Agarwal N, Garg R, Singh S, et al. Coronavirus disease 2019 in pregnancy: Maternal and perinatal outcome. J Educ Health Promot 2021:10(1)194. DOI: 10.4103/jehp.jehp_954_20.
  17. Malhotra J, Agarwal P, Garg R, et al. Corona virus disease (COVID-19) and pregnancy: What obstetrician should know. JSAFOG 2019;11(6):337–339. DOI: 10.5005/jp-journals-10006-1744.
  18. Malhotra N, Garg R, Singh S, et al. Pregnancy management in coronavirus disease – Challenges in developing countries. J Reprod Healthcare Med 2021;2:18. DOI: 10.25259/JRHM_58_2020.
  19. Malhotra N, Malhotra N, Garg R. COVID and women's health in India. J Indian Med Assoc 2022;119(3).
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.